Bone Biologics Corp (BBLGW) Cash from Investing Activities (2014 - 2015)
Bone Biologics (BBLGW) posted quarterly Cash from Investing Activities of -$504.0 for Q1 2015, down 102.68% year-over-year from $18820.0 in Q1 2014, and up 95.77% quarter-over-quarter from -$11901.0 in Q4 2014.
Bone Biologics Corp (BBLGW) Cash from Investing Activities (2014 - 2015) Analysis & Trends
Bone Biologics (BBLGW) has reported Cash from Investing Activities for 2 consecutive years, with -$504.0 the latest figure, recorded in Q1 2015.
- In Q1 2015, Cash from Investing Activities fell 102.68% year-over-year to -$504.0; the TTM figure through Dec 2015 stood at -$504.0 (down 101.98% YoY), while the FY2015 annual figure was -$504.0, down 101.98% from the prior year.
- Cash from Investing Activities advanced to -$504.0 in Q1 2015 per BBLGW's latest filing, from -$11901.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $18820.0 in Q1 2014 and bottomed at -$11901.0 in Q4 2014.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | -504.00 |
| Mar 31, 2015 | -504.00 |
| Dec 31, 2014 | -11,901.00 |
| Dec 31, 2014 | -11,901.00 |
| Jun 30, 2014 | 18,557.00 |
| Jun 30, 2014 | 18,557.00 |
| Mar 31, 2014 | 18,820.00 |
| Mar 31, 2014 | 18,820.00 |